611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
Colon Cancer Screenings Increase When Medicaid ArrivesPoor Diet Might Raise Your Cancer Risk'Watchful Waiting' Less Likely for Black Prostate Cancer PatientsAggressive Approach to Pancreatic Cysts May Prevent Dreaded CancerColon Cancer Increasingly Striking the Young WorldwideTrans Women Have Raised Odds of Breast Cancer, But Risk Still Small: StudyIs That Prostate Cancer Worth Treating? Chromosomes May TellLooking to Whales for Insight on Human CancersIs AI a New Weapon in Breast Cancer Detection?Use of Meds for Enlarged Prostate Might Delay a Cancer DiagnosisDoes Hormone Therapy for Prostate Cancer Raise Dementia Risk?Red Tape Means Many Cancer Patients Get Radiation Treatments LateDevice Spots Lymphedema Early in Breast Cancer Patients, to Help Stop ItGene Therapy May Help Fight Tough-to-Treat Blood CancerHealth Tip: Managing Nausea for Cancer PatientsOne High Dose of Radiation May Be Enough for Early Prostate CancerMany Cardiologists Ill-Equipped to Treat Heart Disease in Cancer SurvivorsStudy Supports Radiation for Early, Hormone-Driven Breast CancerNot All Cervical Cancer Rates Are DecliningMedical Marijuana Use Rising Among Cancer PatientsWith Weeks to Live, Many Cancer Patients Try Useless TreatmentsBalversa Approved for Advanced Bladder CancerChemo Drug Shortages Have Little Effect on Cancer Care: StudyMany Cancer Patients Take Alternative Meds But Don't Tell Their DoctorsNew 'Cancer Vaccine' Attacks Tumors From WithinAHA News: How Can Therapy for Heart Attack Patients Help Cancer Survivors?Researchers Seek Firefighters for Data on Cancer RiskDoes Cancer Battle Bring Personal Growth? Yes and No, Survivors SayIbrance Approval Expanded to Include Men With Breast CancerBirth Control Pills May Protect Against Most Serious Ovarian Cancer: StudyTreatment Advances Making Pancreatic Cancer a Less Deadly DiseaseU.S. Leads World in Reducing Prostate Cancer CasesSurgery May Boost Outcomes in Common Form of Advanced Breast CancerPancreatic Cancer Survival Odds Linked to Weight Before Age 50Dual-Drug Therapy May Boost Odds Against a Tough Breast CancerChoose the Right Colon Cancer Screening OptionMedicaid Coverage for Lung Cancer Screening All Over the MapCould the U.S. Mail Deliver Better Colon Cancer Screening Rates?Baby Monkey May Offer Hope to Preserving Fertility of Kids With CancerDrug Combo Does Double Duty Against Common Skin Lesions, CancersTecentriq Approved for Small Cell Lung CancerHormonal Therapy for Prostate Cancer Might Raise Depression RiskGenomics Could Improve Treatment of Pancreatic CancerScientists Spot Clues to Predicting Breast Cancer's ReturnAI Takes Aim at Lung Cancer Screening'Jeopardy!' Host Alex Trebek Reveals He Has Pancreatic CancerLow-Dose Aspirin Doesn't Prolong Survival in Prostate CancerExercise Might Slow Colon Cancer's AdvanceHigh Deductibles May Threaten Breast Cancer Patients' SurvivalLifestyle Changes Can Lower Your Breast Cancer Risk
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Trans Women Have Raised Odds of Breast Cancer, But Risk Still Small: Study

HealthDay News
by -- Robert Preidt
Updated: May 15th 2019

new article illustration

WEDNESDAY, May 15, 2019 (HealthDay News) -- Transgender women on gender-confirming hormone therapy have increased odds of breast cancer, but the overall risk is low and not as high as it is for the general female population, a new study finds.

Trans women are those who were declared male at birth but identify as female.

Previous research has shown that hormone replacement therapy (HRT) increases breast cancer risk in postmenopausal women, but it was unclear whether the same was true for trans women receiving hormone treatment.

The new study looked at 2,260 trans women and 1,229 trans men who received gender-affirming hormone therapy at a clinic in the Netherlands between 1972 and 2016.

The researchers found that trans women on hormone therapy had a higher breast cancer risk than the general male population. And transgender men (female sex assigned at birth, male gender identity) were found to have a lower breast cancer risk than the general female population.

Average age at the start of hormone treatment was 31 for trans women and 23 for trans men, and average treatment time was 13 years for trans women and eight years for trans men, according to the report.

Among the trans women, 15 cases of invasive breast cancer were diagnosed at an average age of 50. On average, those patients had received hormone treatment for 18 years.

That rate was higher than that in the overall male population but lower than the general female population, according to the study published May 14 in the BMJ.

Among the trans men, four cases of invasive breast cancer were identified. The patients' average age was 47, and they had 15 years of hormone treatment, on average. That rate was lower than in the general female population.

The results show that the overall risk of breast cancer in transgender people is low, so current screening guidelines are sufficient for those on hormone therapy, according to the study authors.

The researchers were led by Martin den Heijer, of the department of internal medicine/endocrinology at University Medical Center in Amsterdam.

The researchers pointed out that breast cancer risk among trans women rose after a relatively short period of hormone treatment. "It would be worthwhile for future studies to investigate in more detail the cause of breast cancer in transgender people receiving hormone treatment," the authors concluded in a journal news release.

Because this was an observational study, it cannot prove cause and effect. In addition, the researchers noted some limitations of the study, including missing or incomplete data about type of hormone use, family history, genetic mutations, tobacco and alcohol use, and body mass index.

More information

The University of California, San Francisco Transgender Care has more on hormone therapy.